ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: GM Prizes: Einhorn, McMahon, Nusslein-Volhard; James, Poznanski Lead Roentgen Ray Society

June 26, 1992

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

Diet/Nutrition Advisory Group Blast Fund Limit, Incurs Schmidt Wrath

February 4, 1977

Presidential Candidates Promise Increases In Funding For Cancer Research, Prevention.

September 14, 2007

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986